107 related articles for article (PubMed ID: 12625033)
1. DU-127090 Solvay/H Lundbeck.
Wolf W
Curr Opin Investig Drugs; 2003 Jan; 4(1):72-6. PubMed ID: 12625033
[TBL] [Abstract][Full Text] [Related]
2. Sumanirole Pharmacia.
de Paulis T
Curr Opin Investig Drugs; 2003 Jan; 4(1):77-82. PubMed ID: 12625034
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of cariprazine.
Stahl SM
CNS Spectr; 2016 Apr; 21(2):123-7. PubMed ID: 26956157
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents.
Norman MH; Rigdon GC; Hall WR; Navas F
J Med Chem; 1996 Mar; 39(5):1172-88. PubMed ID: 8676355
[TBL] [Abstract][Full Text] [Related]
6. Repinotan Bayer.
Lutsep HL
Curr Opin Investig Drugs; 2002 Jun; 3(6):924-7. PubMed ID: 12137415
[TBL] [Abstract][Full Text] [Related]
7. Molecule of the month. Bifeprunox mesilate.
Drug News Perspect; 2005 Oct; 18(8):523. PubMed ID: 16391722
[No Abstract] [Full Text] [Related]
8. SLV-308. Solvay.
Wolf WA
Curr Opin Investig Drugs; 2003 Jul; 4(7):878-82. PubMed ID: 14619412
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
10. Siramesine H Lundbeck.
Heading C
Curr Opin Investig Drugs; 2001 Feb; 2(2):266-70. PubMed ID: 11816842
[TBL] [Abstract][Full Text] [Related]
11. BL-1020, an oral antipsychotic agent that reduces dopamine activity and enhances GABAA activity, for the treatment of schizophrenia.
Fitzgerald PB
Curr Opin Investig Drugs; 2010 Jan; 11(1):92-100. PubMed ID: 20047163
[TBL] [Abstract][Full Text] [Related]
12. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
Stahl SM; Shayegan DK
J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
[TBL] [Abstract][Full Text] [Related]
13. Donitriptan (Pierre Fabre).
Dukat M
Curr Opin Investig Drugs; 2001 Mar; 2(3):415-8. PubMed ID: 11575714
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacology of anxiolytics and their therapeutic use].
Tada K
Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
[No Abstract] [Full Text] [Related]
15. ACS chemical neuroscience molecule spotlight on Fanapt.
Hopkins CR
ACS Chem Neurosci; 2010 Jun; 1(6):410. PubMed ID: 22778835
[TBL] [Abstract][Full Text] [Related]
16. Receptor mechanisms in the treatment of schizophrenia.
Reynolds GP
J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
[TBL] [Abstract][Full Text] [Related]
17. [Aripiprazol. An atypical neuroleptic with exceptional mechanisms of action] ].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2004 Nov; 27(11):364-7. PubMed ID: 15566230
[No Abstract] [Full Text] [Related]
18. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
19. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
[TBL] [Abstract][Full Text] [Related]
20. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]